|Articles|January 2, 2004

Pharmaceutical Technology

  • Pharmaceutical Technology-01-02-2004
  • Volume 28
  • Issue 1

The Bioterrorism Act

Two FDA final rules issued in response to the Bioterrorism Response Act of 2002 may significantly affect the supply and importation of pharmaceutical excipients.
External Link - article-81478.pdf

Articles in this issue

almost 22 years ago

Coprocessed Excipients for Solid Dosage Forms

almost 22 years ago

Manufacturing Execution Systems

almost 22 years ago

State-of-the-Art Packaging Machines

almost 22 years ago

January 2004

almost 22 years ago

Medicare Bill Contains Significant Changes for Drug Manufacturers

almost 22 years ago

Establishing and Maintaining an Effective Gas Evaluation and Management Program

almost 22 years ago

New Supply-Chain Dynamics

almost 22 years ago

In the Spotlight--February 2004

almost 22 years ago

January 2004

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us